Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 3156 Rampart Road, Fort Collins, CO.
Center for Vector Biology & Zoonotic Diseases, The Connecticut Agricultural Experiment Station, New Haven, CT.
J Med Entomol. 2021 Jul 16;58(4):1588-1600. doi: 10.1093/jme/tjaa079.
Lyme and other tick-borne diseases are increasing in the United States. Development of tick control tools have focused primarily on the blacklegged tick, Ixodes scapularis Say. Application of acaricides or entomopathogenic fungal agents to kill host-seeking ticks or ticks on rodents can suppress I. scapularis abundance in residential landscapes, but evidence is lacking for impact on human tick bites or tick-borne disease. Similar studies remain limited for the lone star tick, Amblyomma americanum (L.). Other knowledge gaps include how well homeowners and pest control companies perform in the broadcast application of tick-killing products, relative to high efficacy reported in research studies, and the tick-killing potential of natural product formulations exempt from Environmental Protection Agency registration. Area-wide control based on preventing ticks from feeding on their main reproductive host, the white-tailed deer, can suppress populations of both I. scapularis and A. americanum. Some studies also suggest an impact on Lyme disease cases, but this needs to be further validated in larger-scale intervention studies. The effectiveness, scale, cost, and implementation of various tick management strategies are important considerations in efforts to reduce human tick encounters and tick-borne disease. Additional barriers include weak incentives for industry and academia to develop, test, and register new tick and pathogen control technologies, including vaccines targeting humans, tick reproductive hosts, or wildlife pathogen reservoirs. Solutions will need to be 'two-pronged': improving the tick and pathogen control toolbox and strengthening the public health workforce engaging in tick control at local and state levels.
在美国,莱姆病和其他蜱传疾病的发病率正在上升。蜱类防治工具的开发主要集中在黑腿蜱(Ixodes scapularis Say)上。应用杀蜱剂或昆虫病原真菌剂来杀死宿主寻找的蜱虫或啮齿动物身上的蜱虫,可以抑制住宅景观中黑腿蜱的丰度,但缺乏对人类蜱叮咬或蜱传疾病影响的证据。对于孤星蜱(Amblyomma americanum (L.)),类似的研究仍然有限。其他知识空白包括房主和害虫防治公司在广泛应用杀蜱产品方面的表现如何,相对于研究报告中高功效的表现,以及免予美国环保署注册的天然产品配方的杀蜱潜力。基于防止蜱虫以其主要繁殖宿主白尾鹿为食的区域控制,可以抑制黑腿蜱和孤星蜱的种群数量。一些研究还表明对莱姆病病例有影响,但这需要在更大规模的干预研究中进一步验证。各种蜱类管理策略的有效性、规模、成本和实施情况是减少人类蜱虫接触和蜱传疾病的重要考虑因素。其他障碍包括行业和学术界缺乏开发、测试和注册新的蜱虫和病原体控制技术的动力,包括针对人类、蜱虫繁殖宿主或野生动物病原体库的疫苗。解决方案需要“双管齐下”:一是改善蜱虫和病原体控制工具箱,二是加强在地方和州一级参与蜱虫控制的公共卫生劳动力。